DECONTAMINATION
two” as the engineer always arrives with the required part and spares are never an issue. Quarterly and annual test reports are sent
to Tracey Miller, the Trust’s AE(D), for sign off. She commented that iM Med has made the process easy.
“I am more than happy with the content and the quality of the validation reports that are presented for audit,” said Tracey Miller. “We also know that any queries are answered rapidly by iM Med, so our time is not impacted.”
Discussing their move to iM Med chemicals, Abdul said: “We’d been working with iM Med for one and a half years before we looked at their chemicals. We felt safe with iM Med, with the care and service we were receiving. It gave us a good feeling about moving to them for the chemicals.” iM Med produces the disinfectant and detergent required for a range of EWDs by designing and manufacturing equivalent type tested recipes in a UK manufacturing plant. This enables NHS Trusts to make a choice based on safety and quality to transition to iM Med for the provision chemistry. It also provides an opportunity for Trusts to open-up the procurement of service and consumables, allowing hospitals to procure based on quality for the life costs of their equipment, without being restricted to manufacturer-only purchasing. “There’s a cost saving with the chemicals
too, which is always good. Again, that’s recouped into the service provision,” commented Jenny.
The conversion to iM Med chemistry commenced in 2020, with each machine tested with the chemistry and the resulting report signed-off by the Trust’s AE(D). With the use of the chemicals being slightly different, training was included as part of the
iM Med supplies the EDU with quality, cost-saving consumables, including transport bags
service and delivered by Zoe Fayers Rust, iM Med’s compliance division manager. There had been issues with the dosing system of the previous chemicals, which used a needle to pierce the silicon top of the container. The machines had alarmed due to leaks. iM Med’s chemicals use a different dosing system, without silicon, or piercing. The staff find the connection process very straightforward and there have been no issues with the machines or the chemicals. Significant cost savings have also been made on consumables, as Abdul explained: “iM Med supply the connectors for the machines and there’s a massive price difference and no difference in quality – which is very good. They also supply the clear and red bags for transporting the scopes and we’ve saved money on that too.” The JAG audit for compliance requires
endoscope decontamination departments to have a peracetic acid monitor installed for the safety of patients and staff. iM Med is the sole UK distributor of the ChemDAQ peracetic acid monitoring system. The plug and play system provides continuous monitoring and recording, giving tracking for JAG monthly reports. These can be time- weighted and downloaded. Jenny commented: “ChemDAQ was installed in February this year to meet staff safety requirements and we had training from iM Med in how to use it. The system gives assurance on levels and will alarm green or red and audibly when certain levels are reached. But we’ve had no issues. All reports have been good.” ChemDAQ is now installed in the EDU at each of the Trust’s hospitals: Basingstoke and North Hampshire Hospital, Andover War Memorial Hospital and Royal Hampshire County Hospital, in Winchester. Helena Tilley, iM Med’s account manager,
The ChemDAQ peracetic acid monitoring system, a recommendation of Best Practice by JAG, helps ensure staff safety. iM Med is the sole UK distributor
SEPTEMBER 2021
said: “We have a 100% service contract retention rate and quick response times focused on a first-time fix. We understand what our customers require to deliver safe patient care. Also, the chemistry is manufactured in the UK, so there are never any problems with delivery. That’s a big plus for users.” Abdul added: “The service contract we have with iM Med is working very well and we’ve renewed the contract for the third year. That shows things are going well. There are no delays with consumables or chemicals and the staff are happy with the chemicals and feel safer. Other hospitals have been to see the department and to talk to us, for our feedback on the service and the chemicals. It gives them a much better perspective when they can talk to the user. When we were looking to take on iM Med, we got references from other hospitals. Now we give references.”
CSJ
WWW.CLINICALSERVICESJOURNAL.COM l 31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
